WNK2 and Alzheimer disease: CREB is considered to play a critical role in AD drug responses [34] and pCREBSer133 is induced by a variety of signalling pathways, including PKA (protein kinase A), Ca2+-calmodulin kinase II and Mitogen-activated protein kinase pathways [35].